So — that pig-to-hu­man trans­plant; Po­ten­tial di­a­betes cure reach­es pa­tient; Ac­cused MIT sci­en­tist lash­es back; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We’re in­cred­i­bly ex­cit­ed to wel­come Beth Bu­lik, sea­soned phar­ma mar­ket­ing re­porter, to the team. You can find much of her work in our new Mar­ket­ing chan­nel — and in her week­ly newslet­ter, End­points Phar­maRx, which will launch in ear­ly No­vem­ber. Add it to your sub­scrip­tions here.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER